Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
American Journal of Pharmaceutical Education|May 1, 2012
An advanced clinical track within a doctor of pharmacy programJames New, Sandra Garner, Kelly Ragucci, et al.
Journal of Water and Health|October 14, 2006
The health effects of flooding: Social research results from England and WalesSylvia Tunstall, Sue Tapsell, Colin Green, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 8, 2022
Considering Severity in Health Technology Assessment: Can We Do Better?Chris Skedgel, Nadine Henderson, Adrian Towse, et al.
International Journal of Technology Assessment in Health Care|May 6, 2006
Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United KingdomColin Green, Jacqueline Dinnes, Andrea L Takeda, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6DAnnie Hawton, Colin Green, Claire Telford, et al.
Journal of Neurology|August 6, 2011
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's diseaseJames Shearer, Colin Green, Carl E Counsell, et al.
Drugs & Aging|December 24, 2011
Health state values for use in the economic evaluation of treatments for Alzheimer's diseaseJames Shearer, Colin Green, Craig W Ritchie, et al.
Nitric Oxide : Biology and Chemistry|September 12, 2002
Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stressEkaterina Monastyrskaya, Najeem Folarin, Igor Malyshev, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 16, 2011
Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progressionColin Green, James Shearer, Craig W Ritchie, et al.
Pageof 20